ECM
ONCT

Element Capital Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Element Capital Management’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-94
Closed -$234K – 1045
2018
Q1 		$234K Buy
+94
New +$209K 0.01% 601

Other funds holding ONCT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Element Capital Management's ONCT Position: Q2 2018 in Review

Element Capital Management sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2018, closing a stake of 94 shares — an estimated $234K sold.

Element Capital Management first reported a position in ONCT in Q1 2018 and held it in 1 quarter. The position peaked at $234K in Q1 2018. 55 funds tracked by Wall St. Rank hold ONCT as of Q2 2018.

  • Element Capital Management reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Element Capital Management sold 94 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $234K.
  • Element Capital Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Element Capital Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $234K in Q1 2018.
  • 55 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.